Atlas Trials

Topotecan in Combination With Gemcitabine in Patients With Platinum-resistant Ovarian Carcinoma

Clinical trial NCT00429559 · COMPLETED

Trial details

NCT number
NCT00429559
Sponsor
Hellenic Oncology Research Group
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Ovarian Cancer
Start date
2006-06-01
Primary completion
2011-07-01
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.